Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

ML Marinovich, N Houssami, P Macaskill… - Journal of the …, 2013 - academic.oup.com
Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Current Status of Breast MR Imaging Part 2. Clinical Applications1

CK Kuhl - Radiology, 2007 - pubs.rsna.org
Magnetic resonance (MR) imaging is emerging as the most sensitive modality that is
currently available for the detection of primary or recurrent breast cancer. Although this …

Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI

NM Braman, M Etesami, P Prasanna, C Dubchuk… - Breast Cancer …, 2017 - Springer
Background In this study, we evaluated the ability of radiomic textural analysis of
intratumoral and peritumoral regions on pretreatment breast cancer dynamic contrast …

Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer

E Yeh, P Slanetz, DB Kopans… - American Journal of …, 2005 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to determine the relative accuracy of
mammography, sonography, and MRI in predicting residual tumor after neoadjuvant …

MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature

RM Mann, YL Hoogeveen, JG Blickman… - Breast cancer research …, 2008 - Springer
Purpose The clinical diagnosis and management of invasive lobular carcinoma (ILC) of the
breast presents difficulties. Magnetic resonance imaging (MRI) has been proposed as the …

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T1

S Meisamy, PJ Bolan, EH Baker, RL Bliss, E Gulbahce… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine if changes in the concentration of choline-containing compounds
(tCho) from before primary systemic therapy (PST) to within 24 hours after the first treatment …

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results

TE Yankeelov, M Lepage, A Chakravarthy… - Magnetic resonance …, 2007 - Elsevier
PURPOSE: The objective of this study was to assess changes in the water apparent
diffusion coefficient (ADC) and in pharmacokinetic parameters obtained from the fast …

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model

TE Yankeelov, JJ Luci, M Lepage, R Li… - Magnetic resonance …, 2005 - Elsevier
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess tumor
perfusion, microvascular vessel wall permeability and extravascular–extracellular volume …

Imaging angiogenesis: applications and potential for drug development

JC Miller, HH Pien, D Sahani… - Journal of the …, 2005 - academic.oup.com
Recognition of the importance of angiogenesis to tumor growth and metastasis has led to
efforts to develop new drugs that are targeted to angiogenic vasculature. Clinical trials of …

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

MD Pickles, M Lowry, DJ Manton, P Gibbs… - Breast cancer research …, 2005 - Springer
Neoadjuvant chemotherapy has become the standard treatment for patients with locally
advanced breast cancer; however a technique that can accurately differentiate responders …